Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“This weekend, I was in Nagasaki for the Japan College of Cardiology meeting.
It was a productive trip and a great opportunity to connect in person with investigators and colleagues participating in our FXI studies in atrial fibrillation and peripheral artery disease.
Beyond the scientific discussions, I really enjoyed learning more about Nagasaki and its unique place in Japanese history.
For centuries, Nagasaki served as Japan’s sole trading port open to foreign countries, making it an important gateway for international exchange and the exchange of ideas.
It was a great visit all around, and I’m grateful to all of the investigators and colleagues who took the time to meet, share their insights, and advance our work together.
Looking forward to many more years of collaboration and continuing the important work we are doing together in thrombosis.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy